The Quantum Group Executes Plan to Expand Medicare Advantage Options to Include Seven Florida Counties
10 Fevereiro 2005 - 2:49PM
PR Newswire (US)
The Quantum Group Executes Plan to Expand Medicare Advantage
Options to Include Seven Florida Counties WELLINGTON, Fla., Feb. 10
/PRNewswire-FirstCall/ -- The Quantum Group, Inc. (OTC:QTUM)
(BULLETIN BOARD: QTUM) announced today that it has executed a
second Letter of Intent with a Florida Health Maintenance
Organization (HMO) to build and manage a new Medicare Advantage
Community Health System (CHS) in an additional five Florida
counties, bringing Quantum's CHS to seven counties. "Through this
newly expanded territory and other opportunities currently in
negotiation and development, we expect to have material operations
before the end of 2005 and have aggressive CHS expansion into
2006," commented Noel J. Guillama, president of The Quantum Group,
Inc. Mr. Guillama further commented, "We now have a mandate to
build and manage Community Health Systems in seven of the most
dynamic and growing counties in Florida. These counties
collectively have a total Medicare-eligible population of over
400,000 individuals -- of which approximately only 75,000 are
currently enrolled in the Medicare Advantage program. We seek to
provide more alternatives to the more than 375,000 people that have
not joined the program." Renaissance Health Systems (RHS), a
division of the Quantum family of companies, will be responsible
for the management of the day-to-day operations. The mission of RHS
is to provide quality, proactive, and cost effective healthcare to
our patients, while simultaneously improving their quality of life
and lifestyle. The Quantum Group, Inc. is a Wellington,
Florida-based healthcare company, providing outsourcing,
technology-based solutions, government compliance, education,
policy consulting and venture management to the healthcare
industry. Quantum is currently involved in: outsourcing for
physicians, managed care organizations, healthcare facilities, and
physician associations; developing three patent-pending healthcare
solutions identified as Cybernaptics(SM), Quantum Quotient(SM) (or
QX2)(SM) and MDAutomated(SM), all with the intention to provide new
efficiencies to the $1.79 trillion U.S. healthcare system; and
providing leading-edge healthcare services to consumers. The
Quantum Group -- "healthcare solutions for a new generation."(SM)
Certain statements contained in this news release, which are not
based on historical facts, are forward-looking statements as the
term is defined in the Private Securities Litigation Reform Act of
1995, and are subject to uncertainties and risks in part detailed
in the respective company's Securities and Exchange Commission
10-K, 10-Q, S-8 and 8-K filings, that may cause actual results to
materially differ from projections. Although the company believes
that its expectations are reasonable assumptions within the bounds
of its knowledge of its businesses and operations; there can be no
assurance that actual results will not differ materially from their
expectations. Important factors currently known to management that
could cause actual results to differ materially from those in
forward-looking statements include the company's ability to execute
properly its new business model, to raise additional capital to
implement new business model, the ability to attract and retain
personnel, and the inherent risk associated with a diversified
business to achieve positive cash flow. In light of these risks and
uncertainties, there can be no assurance that the forward-looking
information contained in this report will, in fact, occur. Media
Contact: Danielle Amodio Director of Corporate Communications The
Quantum Group, Inc. 561.798.9800 DATASOURCE: The Quantum Group,
Inc. CONTACT: Danielle Amodio, Director of Corporate
Communications, The Quantum Group, Inc., +1-561-798-9800 Web site:
http://www.thequantumgroupinc.com/
Copyright